The results of the therapeutic efficacy studies using the NSB drug, as shown in Figure 7 , are highly significant because doses in the range of 3–7 mg per 30 gm mouse, administered two times a week, are able to control the growth and proliferation in a highly effective way as compared to the untreated control groups.
← all excerpts
New Approaches in Breast Cancer Therapy Through Green Nanotechnology and Nano-Ayurvedic Medicine - Pre-Clinical and Pilot Human Clinical Investigations.
1
—
—